Hester Biosciences
1,583.70
-9.30(-0.58%)
Market Cap₹1,347.23 Cr
PE Ratio30.48
IndustryHealthcare
Company Performance:
1D-0.58%
1M-3.61%
6M-12.25%
1Y-34.12%
5Y-8.56%
View Company Insightsright
More news about Hester Biosciences
09May 25
Hester Biosciences Declares Dividend Amidst Q4 Profit Decline
Hester Biosciences announced a ₹7 per share dividend despite a 73.74% drop in Q4 consolidated net profit to ₹13 million. Revenue increased by 4.05% to ₹72 crore, while sales decreased by 5.67%. EBITDA rose 11.29%, but operating profit halved. The company reported a significant increase in other income to ₹8.80 crore, potentially offsetting operational challenges.
Hester Biosciences
1,583.70
-9.30
(-0.58%)
1 Year Returns:-34.12%
Industry Peers
Sun Pharmaceutical
1,737.00
(-1.08%)
Divis Laboratories
6,496.50
(+0.31%)
Torrent Pharmaceuticals
3,834.30
(+0.37%)
Cipla
1,496.30
(-0.29%)
Dr Reddys Laboratories
1,265.80
(-1.38%)
Lupin
2,107.00
(-0.31%)
Zydus Life Science
917.80
(-1.08%)
Mankind Pharma
2,193.30
(-1.63%)
Aurobindo Pharma
1,211.40
(-0.54%)
Alkem Laboratories
5,566.00
(-0.55%)